Abstract
2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Yackov Berkun, Iman Abou Atta, Alan Rubinow, Hedi Orbach, David Levartovsky, Suhail Aamar, Ofer Arbel, Rivka Dresner-Pollak, Gideon Friedman and Arie Ben-Yehuda
The Journal of Rheumatology August 2007, 34 (8) 1664-1669;
Yackov Berkun
Iman Abou Atta
Alan Rubinow
Hedi Orbach
David Levartovsky
Suhail Aamar
Ofer Arbel
Rivka Dresner-Pollak
Gideon Friedman
In this issue
The Journal of Rheumatology
Vol. 34, Issue 8
1 Aug 2007
2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Yackov Berkun, Iman Abou Atta, Alan Rubinow, Hedi Orbach, David Levartovsky, Suhail Aamar, Ofer Arbel, Rivka Dresner-Pollak, Gideon Friedman, Arie Ben-Yehuda
The Journal of Rheumatology Aug 2007, 34 (8) 1664-1669;
2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Yackov Berkun, Iman Abou Atta, Alan Rubinow, Hedi Orbach, David Levartovsky, Suhail Aamar, Ofer Arbel, Rivka Dresner-Pollak, Gideon Friedman, Arie Ben-Yehuda
The Journal of Rheumatology Aug 2007, 34 (8) 1664-1669;